申请人:ALLERGAN, INC.
公开号:US20130150413A1
公开(公告)日:2013-06-13
The present invention relates to novel benzisothiazol-3(1H)-one-5-sulfonyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.
本发明涉及新型苯并异噻唑-3(1H)-酮-5-磺酰衍生物,其制备方法,含有它们的药物组合物以及它们作为药物的用途,用作化学因子受体的调节剂。